Clinical Trial Update: CD19/CD22 CAR-T Cell Therapy in MRD-Positive B-lineage Acute Lymphoblastic Leukemia in Children. [Phase 1]

View source ↗

Summary

This clinical trial update describes a Phase 1 study of a CD19/CD22 CAR-T cell therapy for MRD-positive B-lineage acute lymphoblastic leukemia in children, curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• CD19/CD22 CAR-T cell therapy

Snippet

Sponsor: Guangzhou Women and Children's Medical Center | Conditions: Acute Lymphoblastic Leukemia | Phase 1 | Status: RECRUITING